Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod-Reference-Cited by-同舟云学术

Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod

Published:2022-08-29 Issue:1 Volume:44 Page:361-363
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Morillos Matheus Bernardon,de Aguiar Paulo Henrique Pires,Franceschini Paulo Roberto,Duarte Juliana Ávila,Piccini Cristian Daniel^ORCID,Finkelsztejn Alessandro

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-022-06367-3.pdf

Reference13 articles.

1. Citterio G, Reni M, Gatta G, Ferreri AJM (2017) Primary central nervous system lymphoma. Crit Rev Oncol Hematol 113:97–110. https://doi.org/10.1016/j.critrevonc.2017.03.019

2. Garg N, Smith TW (2015) An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav. 5(9):e00362. https://doi.org/10.1002/brb3.362

3. Chun J, Kihara Y, Jonnalagadda D, Blaho VA (2019) Fingolimod: lessons learned and new opportunities for treating multiple sclerosis and other disorders. Annu Rev Pharmacol Toxicol 6(59):149–170. https://doi.org/10.1146/annurev-pharmtox-010818-021358

4. Kawai H, Matsushita H, Akashi H, Furuya D, Kawakami S, Suzuki R, Moriuchi M, Ogawa Y, Kawada H, Nakamura N, Ando K (2020) Peripheral T-cell lymphomas as fingolimod-associated lymphoproliferative disorder for patients with multiple sclerosis - case report with literature review. Leuk Lymphoma 61(4):959–962. https://doi.org/10.1080/10428194.2019.1691197

5. Mahale P, Herr MM, Engels EA, Pfeiffer RM, Shiels MS (2020) Autoimmune conditions and primary central nervous system lymphoma risk among older adults. Br J Haematol. 188(4):516–521. https://doi.org/10.1111/bjh.16222

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review;Journal of Neuroimmunology;2024-09

2. How do sphingosine-1-phosphate affect immune cells to resolve inflammation?;Frontiers in Immunology;2024-02-28

3. A Case Report of Brain Lymphoproliferative Disease After Mycophenolate Mofetil and Fingolimod Therapy;2024

4. A Case of Primary Central Nervous System Lymphoma That Developed in a Patient Receiving Fingolimod Therapy for Multiple Sclerosis;Cureus;2023-12-26

5. Cytarabine/fingolimod/methotrexate;Reactions Weekly;2023-02-04